Regulatory Science and Policy Events

Stay up to date on upcoming Regulatory and Science Policy Workshops, as well as policy issues affecting cancer research, by reading and subscribing to the AACR Cancer Policy Monitor.

recent events

• FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases (May 9, 2024)
• FDA-AACR Public Workshop: Optimizing Dosages for Oncology Drug Products (February 15-16, 2024)

Past Events

• FDA-AACR-ASA Workshop: Overall Survival in Oncology Clinical Trials (July 18, 2023)
• Regulatory Science and Policy Track at the AACR Annual Meeting 2023 (April 14-19, 2023)
• Regulatory Science and Policy Track at the AACR Annual Meeting 2022 (April 8-13, 2022)
• Regulatory Science and Policy Track at the AACR Virtual Annual Meeting (May 17-21, 2021)
• Regulatory Science and Policy Track at the AACR Virtual Annual Meeting (June 22-24, 2020)
• NIH-AACR Cancer, Autoimmunity, and Immunology Conference 2020 (March 23-24, 2020)
• FDA-AACR-IASLC Workshop to Address the Criticality of Tobacco Use Assessment in Oncology Therapeutic Trials (February 28, 2020)
• FDA-AACR Workshop to Examine Under-representation of African Americans in Multiple Myeloma Clinical Trials (February 13, 2020)
• FDA-AACR Real-world Evidence Workshop (July 19, 2019)
• NIH-AACR Cancer, Autoimmunity, and Immunology Conference (April 15-16, 2019)
• (March 29-April 3, 2019)
• FDA-AACR Non-clinical Models for Safety Assessment of Immuno-oncology Products Workshop (September 6, 2018)
• FDA-AACR-SGO Drug Development for Gynecological Malignancies Workshop (June 14, 2018)
• Regulatory Science and Policy Track at the AACR Annual Meeting 2018 (April 14-18, 2018)
• FDA-AACR-ASTRO Clinical Development of Drug-Radiotherapy Combinations Workshop (February 22-23, 2018)
• FDA-AACR Liquid Biopsies in Oncology Drug and Device Development Workshop Part II (October 10, 2017)
• FDA-AACR Oncology Dose-finding Workshop Part III (July 20, 2017)
• Regulatory Science and Policy Track at the AACR Annual Meeting 2017 (April 1-4, 2017)
• FDA-AACR Immuno-oncology Drug Development Workshop (October 13-14, 2016)
• FDA-AACR Liquid Biopsies in Oncology Drug and Device Development Workshop Part I
• (July 19, 2016)
• FDA-AACR Oncology Dose-finding Workshop Part II (June 13, 2016)
• Regulatory Science and Policy Track at AACR Annual Meeting 2016 (April 16-20, 2016)
• Ovarian Cancer Endpoints Workshop (September 3, 2015)
• Dose-finding of Small Molecule Oncology Drugs Workshop Part I (May 18-19, 2015)
• Regulatory Science and Policy Track at AACR Annual Meeting 2015 (April 18-22, 2015)
• Complexities in Personalized Medicine: Harmonizing Companion Diagnostics Across a Class of Targeted Therapies (March 24, 2015)
• Regulatory Science and Policy Track at AACR Annual Meeting 2014 (April 5-9, 2014)
• FDA-AACR-ASCO-BCRF Innovations in Breast Cancer Drug Development- Next Generation Oncology Trials Workshop (October 21, 2014)
• AACR-AdvaMedDx Cancer Diagnostics Symposium: Transforming Cancer Care through Diagnostics and Personalized Medicine (October 29, 2013)
• AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Combining Immunotherapies, Immune Modulators, and Targeted Therapies: Regulatory Opportunities Challenges (October 23, 2013)
• Regulatory Science and Policy Track at AACR Annual Meeting 2013 (April 6-10, 2013)
• Regulatory Science and Policy Track at AACR Annual Meeting 2012 (March 31- April 4, 2012)